Skip to main content
Caplight Logo









Pragma Clinical

Pragma Clinical

Private
United StatesHealthcare & Life Scienceshttps://app.pragmaclinical.com/

Last Round

Grant

Dec 9, 2024

Total Funding Raised

$636,810

Company Overview

Pragma Clinical is a software company that provides an AI-powered platform for clinical trial protocol analysis, site feasibility, and drug safety intelligence.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Healthcare Analytics, Medical AI, Compliance, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical trial designclinical trial protocolclinical outcome assessmentsCOAsite feasibilityclinical trial softwarepharma techclinical research organizationCROregulatory complianceprotocol optimizationclinical trial recruitmentvertical SaaSAI in healthcaredrug development software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pragma Clinical Comparables

Compare Pragma Clinical with similar companies based on industry and business-model similarity.

Pragma Clinical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Phesi
79%
ZS
76%
Dassault Systèmes
72%

Pragma Clinical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 9, 2024
GrantJul 29, 2024
GrantJul 2, 2024
GrantJun 19, 2024
GrantJan 8, 2024
Grant
Nov 2, 2023

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 2, 2024

    $22K grant received from National Research Council of Canada.

  • Jun 19, 2024

    Received grant from Centre for Aging and Brain Health Innovation.

Pragma Clinical Filings

Explore SEC and related filing metadata, where available.

Pragma Clinical filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pragma Clinical's valuation, stock price, and market status.

Is Pragma Clinical a public or private company?

Pragma Clinical is a private company.

What is the current stock price of Pragma Clinical?

Pragma Clinical is a private company with no public stock price. No recent secondary market data is available.

How much is Pragma Clinical worth (valuation)?

Valuation information for Pragma Clinical is not publicly available.

Can I buy Pragma Clinical stock?

Pragma Clinical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pragma Clinical's last funding round?

Pragma Clinical's most recent funding round was Grant on December 9, 2024.

Who are the main investors in Pragma Clinical?

Key investors in Pragma Clinical include Canadian International Innovation Program, Innovation and Business Investment Corporation, Memorial Centre for Entrepreneurship, National Research Council of Canada Industrial Research Assistance Program (NRC IRAP), CanExport.

Will Pragma Clinical IPO soon?

No public IPO plans have been announced for Pragma Clinical.

How can I track Pragma Clinical secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pragma Clinical's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUnited States
Year FoundedN/A
Last FundingDec 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?